Health News Releases

  • Today February 19
May 01, 2015 12:00
Teva Sends Letter to Mylan Board
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that it has sent a letter to Robert J. Coury, Executive Chairman of the Board of Directors of Mylan N.V. (NASDAQ: MYL). The fu
April 28, 2015 13:55
Teva Reiterates Commitment to Cash-and-Stock Acquisition of Mylan for $82.00 Per Share
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today reiterated its commitment to its proposed combination with Mylan N.V. (NASDAQ: MYL). As previously announced on April 21, 2015, Teva has
April 28, 2015 13:45
ElectroCore’s non-invasive vagus nerve stimulation therapy shown to be safe and to produce no meaningful cardiac adverse effects
At the 67th American Academy of Neurology meeting in Washington, DC, last week a poster presentation showed that electroCore’s non-invasive vagus nerve stimulation (nVNS) therapy does not cause any me
April 27, 2015 13:40
Jean Boulle Group Announces First US Clinical Trial
Boulle Medtech Ltd, a Jean Boulle Group medical technology company and the founding investor of Tendyne Holdings, Inc. (“Tendyne”), is pleased to announce that the Tendyne Transcatheter Mitral Valve I
April 23, 2015 10:10
Teva Files for Hart-Scott-Rodino Notification Regarding Proposed Acquisition of Mylan
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) (TASE:TEVA) today announced that it has filed for premerger notification under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR) with the U
April 23, 2015 09:55
Teva Proposes to Acquire Mylan for $82.00 Per Share in Cash and Stock
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced a proposal to acquire all of the outstanding shares of Mylan N.V. (NASDAQ: MYL) in a transaction valued at $82.00 per Mylan sh
April 21, 2015 15:30
4SC Signs Licensing and Development Agreement with Menarini for Resminostat in Asia-Pacific Excluding Japan
4SC AG (Frankfurt, Prime Standard: VSC), a discovery and development company of targeted small molecule drugs for cancer and autoimmune diseases, and Singapore based Menarini Asia-Pacific Holdings Pte
April 21, 2015 12:00
Global Trials Show Addition of Medtronic’s Solitaire™ Device Stent Thrombectomy Procedure in Treatment of Acute Ischemic Stroke Improves Neurological Outcomes
Two global trials published online in The New England Journal of Medicine (NEJM) and presented at the European Stroke Organisation Conference (http://eso.kenes.com) found that the addition of the Soli
April 20, 2015 15:20
Applied Spectral Imaging Received South Korean Ministry of Food and Drug Safety (MFDS) Clearance for GenASIs™ HiPath IHC Family for HER2, ER, PR and Ki67
Applied Spectral Imaging (ASI, www.spectral-imaging.com) announced today that it has received clearance from the South Korean Ministry of Food and Drug Safety (MFDS) for its GenASIs HiPath image captu
April 20, 2015 10:15
New international survey of lung cancer oncologists highlights underutilization of personalized treatments
For media outside the US, the UK and Canada only Results from a new global survey of lung cancer oncologists have shown that despite 81% of newly diagnosed advanced non-small cell lung cancer (NSCL
April 17, 2015 13:55
Quintiles and Hospital Italiano of Buenos Aires Announce Agreement to Accelerate Clinical Development
Quintiles today announced a strategic alliance with Hospital Italiano of Buenos Aires as part of the company’s Prime Site program. Hospital Italiano is Quintiles’ first Prime Site in Latin America, co
April 16, 2015 11:20
Phase II Data for Apremilast in Behçet’s Disease Published in The New England Journal of Medicine
Celgene Corporation (NASDAQ:CELG) today announced that results from a multicenter, randomized, placebo-controlled phase II trial (BCT-001) of apremilast (Otezla®) in patients with Behçet’s disease wer
April 15, 2015 11:20
IncellDx, Inc. Signs Exclusive License with Claremont BioSolutions to Commercialize Novel Liquid-Based Biopsy Technology
IncellDx, Inc. announced today the signing of a worldwide, exclusive license and supply agreement with Claremont BioSolutions (Upland, CA) to couple their enzyme-free tissue homogenization technology
April 14, 2015 19:00
WIN Consortium Appoints Professor Waun Ki Hong as Special Advisor to Oversee Its Combined Targeted Triple-Therapy Strategy Aiming to Achieve Significant Impact on Survival in Metastatic Lung Cancer
Worldwide Innovative Networking - WIN Consortium (www.winconsortium.org) announces today the appointment of Professor Waun Ki Hong from the University of Texas MD Anderson Cancer Center, as Special Ad
April 14, 2015 10:35
Hydra Biosciences and Boehringer Ingelheim Enter Research Collaboration Focused on Renal Diseases and Disorders
Hydra Biosciences, Inc., a leader in the field of transient receptor potential (TRP) channel modulation, and Boehringer Ingelheim today announced that they have entered into a worldwide research colla
April 10, 2015 19:00
Replicor to Present at the 2015 Lancet Viral Hepatitis Conference
Replicor Inc., a privately held biopharmaceutical company targeting a cure for patients with chronic hepatitis B (HBV) and hepatitis D (HDV) infection, today announced that it will present updated cli
April 10, 2015 17:00
IBA and Toshiba Sign Strategic Partnership in Particle Therapy
IBA (Ion Beam Applications S.A.) and Toshiba Corporation (TOKYO:6502) today announce the signing of a global collaboration to expand access to advanced particle therapy worldwide. Toshiba Medical Syst
April 10, 2015 13:15
Quintiles wins Best CRO Award at World Vaccine Congress 2015
For the third time in the last four years, Quintiles has been named Best Clinical Research Organization (CRO) at the Vaccine Industry Excellence (ViE) Awards. Presented at the World Vaccine Congress i
April 09, 2015 11:45
PPD and SNBL Complete Joint Venture to Provide Japanese Clinical Development Services and Additional Collaborations
Pharmaceutical Product Development, LLC (PPD, www.ppdi.com) and Shin Nippon Biomedical Laboratories Ltd. (SNBL, http://snbl.com) (TSE:2395) today announced the closing of an agreement to form a joint
April 03, 2015 13:50
TPG Completes Acquisition of Aptalis Pharmaceutical Technologies, Company Renamed Adare Pharmaceuticals
Aptalis Pharmaceutical Technologies announced today that its divestiture from Actavis plc to TPG, a global private investment firm, has been completed. The company also announced that its new name is
April 01, 2015 11:25
Quintiles and Quest Diagnostics to Form Joint Venture to Provide Global Clinical Trials Laboratory Services
Quintiles (www.quintiles.com) and Quest Diagnostics (http://goo.gl/NbIXp) today announced a definitive agreement to form a global clinical trials laboratory services business. By combining the clinica
March 31, 2015 06:00
World's Largest and Fully-Integrated Healthcare Exhibition “tHIS 2015” to Break Attendance Records This May
The Health Industry Summit (tHIS) 2015 organized by Reed Sinopharm will be held on May 15-18, 2015, at the National Convention & Exhibitions Center in Shanghai, China. Latest figures indicate that the
March 30, 2015 16:15
Type 2 Diabetes: CHMP Recommends Empagliflozin/Metformin Hydrochloride for Approval in the European Union
For media outside the US, the UK and Canada only Boehringer Ingelheim (BI) and Eli Lilly and Company (Lilly) today announced they have received a positive opinion from the Committee for Medicinal P
March 27, 2015 15:45
Galderma Announces Positive Outcome of European Decentralised Procedure for Approval of SOOLANTRA® (ivermectin) Cream 10mg/g for Rosacea Patients
Galderma, a global specialty pharmaceutical company focused on dermatology, announced today a positive outcome of the European Decentralised Procedure (DCP) for SOOLANTRA® (ivermectin) Cream 10mg/g fo
March 25, 2015 14:00
Quintiles’ Anand Tharmaratnam Honored as ‘Asian Male Executive of the Year’ in BioPharma Asia Industry Awards 2015
Quintiles Head of Asia Markets Anand Tharmaratnam (http://goo.gl/KFkhvE), M.D., last night was honored as “Best Life Science Asian Male Executive of the Year” at the BioPharma Asia Industry Awards. Dr
25 per page50 per page75 per page100 per page